230 related articles for article (PubMed ID: 5077306)
1. Relative efficacy. When the government decides what drugs should be prescribed, is the patient better served?
Ohio State Med J; 1972 Aug; 68(8):748-52 passim. PubMed ID: 5077306
[No Abstract] [Full Text] [Related]
2. Relative efficacy. When the government decides what drug should be prescribed, is the patient better served?
J Med Assoc State Ala; 1972 Sep; 42(3):200-12. PubMed ID: 5070864
[No Abstract] [Full Text] [Related]
3. Relative efficacy. When the government decides what drug should be prescribed, is the patient better served?
J Tenn Med Assoc; 1972 Aug; 65(8):748-51. PubMed ID: 4671687
[No Abstract] [Full Text] [Related]
4. Keeping prescription drugs safe and effective.
Bryan PA
Am Fam Physician; 1974 Nov; 10(5):189-93. PubMed ID: 4421343
[No Abstract] [Full Text] [Related]
5. Use of drugs for unapproved indications: your legal responsibility.
Eye Ear Nose Throat Mon; 1972 Dec; 51(12):493-5. PubMed ID: 4637969
[No Abstract] [Full Text] [Related]
6. Drugs and the Washington climate.
Durant TM
Trans Am Clin Climatol Assoc; 1969; 80():196-204. PubMed ID: 4896316
[No Abstract] [Full Text] [Related]
7. [Drug counterfeiting and counter measures. Study by the Hungarian National Alliance Against Drug Counterfeiting].
Psychiatr Hung; 2009; 24(3):205-14. PubMed ID: 20017282
[No Abstract] [Full Text] [Related]
8. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
Dorfman HL; Quinn VM; Brophy EA
Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
[No Abstract] [Full Text] [Related]
9. Instrument of impediment. The regulatory monograph in medical communications.
Archer J
J Kans Med Soc; 1972 Aug; 73(8):385-8. PubMed ID: 5068010
[No Abstract] [Full Text] [Related]
10. Plugs for drugs.
Masson A; Rubin PH
Regulation; 1986; 10(1):37-43, 53. PubMed ID: 10280556
[No Abstract] [Full Text] [Related]
11. Labeling regulations: 'prescribe as directed'.
Regier H
J Leg Med (N Y); 1974; 2(5):48-51. PubMed ID: 4548706
[No Abstract] [Full Text] [Related]
12. Veterinary drug availability.
Gloyd J
J Am Vet Med Assoc; 1980 Apr; 176(7):611-4. PubMed ID: 7372533
[No Abstract] [Full Text] [Related]
13. Development of orphan products.
FDA Drug Bull; 1983 Apr; 13(1):2-4. PubMed ID: 6852406
[No Abstract] [Full Text] [Related]
14. Relative efficacy.
Stetler CJ
J Miss State Med Assoc; 1972 Oct; 13(10):427-32. PubMed ID: 5070310
[No Abstract] [Full Text] [Related]
15. The federal preemption debate in pharmaceutical labeling product liability actions.
Gross JM; Curry JA
Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
[No Abstract] [Full Text] [Related]
16. How does the FDA affect you and your practice?
Novitch M
Leg Aspects Med Pract; 1979 Mar; 7(3):23-6. PubMed ID: 423685
[No Abstract] [Full Text] [Related]
17. Relative efficacy.
Stetler CJ
J Med Assoc Ga; 1972 Sep; 61(9):312-5. PubMed ID: 5080001
[No Abstract] [Full Text] [Related]
18. The case for preemption of prescription drug failure-to-warn claims.
Kim CH
Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
[No Abstract] [Full Text] [Related]
19. Patient package inserts--instructions or intrusions?
Harvey MW
Leg Aspects Med Pract; 1978 Aug; 6(8):47-51. PubMed ID: 703481
[No Abstract] [Full Text] [Related]
20. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
[No Abstract] [Full Text] [Related]
[Next] [New Search]
